Advertisement
Advertisement
TLSI
TriSalus Life Sciences, Inc. Common Stock
4.37
USDSponsored
+0.21
+5.05%
Jun 25, 16:00 UTC -4
Closed
After-Market
4.45
+0.08
+1.83%
TLSI Earnings Reports
Positive Surprise Ratio
TLSI beat 4 of 10 last estimates.
40%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$10.47M
/-$0.15
Implied change from Q1 26 (Revenue/ EPS)
+17.68%
/-600.00%
Implied change from Q2 25 (Revenue/ EPS)
-6.61%
/-44.44%
TriSalus Life Sciences, Inc. Common Stock earnings per share and revenue
On May 12, 2026, TLSI reported earnings of 0.03 USD per share (EPS) for Q1 26, beating the estimate of -0.15 USD, resulting in a 118.86% surprise. Revenue reached 8.90 million, compared to an expected 10.65 million, with a -16.43% difference. The market reacted with a -41.45% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.15 USD, with revenue projected to reach 10.47 million USD, implying an decrease of -600.00% EPS, and increase of 17.68% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Canopy Growth Corporation Common Shares
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.09
Actual
-$0.40
Surprise
-309.74%
High Tide Inc. Common Shares
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.02
Actual
$0.01
Surprise
+135.97%
Aurora Cannabis Inc. Common Shares
Report Date
Jun 11, 2026 For Q4 26
Estimate
-$0.08
Actual
$0.11
Surprise
+228.06%
FAQ
What were TriSalus Life Sciences, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, TriSalus Life Sciences, Inc. Common Stock reported EPS of $0.03, beating estimates by 118.86%, and revenue of $8.90M, -16.43% below expectations.
How did the market react to TriSalus Life Sciences, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -41.45%, changed from $4.56 before the earnings release to $2.67 the day after.
When is TriSalus Life Sciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for TriSalus Life Sciences, Inc. Common Stock's next earnings report?
Based on --
analysts, TriSalus Life Sciences, Inc. Common Stock is expected to report EPS of -$0.15 and revenue of $10.47M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement